all - Opinion Summaries

TAP Pharm. v. Owl Pharm.

Drugs & Biotech, Intellectual Property, Patent
In a patent dispute concerning a prostate cancer drug, defendant's product does not infringe upon plaintiff's patents, either literally or under the...

Hoxie v. DEA

Administrative Law, Drugs & Biotech, Health Law
The DEA's revocation of plaintiff's certificate of registration to prescribe controlled substances was supported by substantial evidence and was not...

Capon v. Eshhar

Drugs & Biotech, Intellectual Property, Patent
In a patent interference proceeding concerning a chimeric gene, the Board of Patent Appeals erred when it dissolved the interference since it...

In Re: Diet Drugs

Civil Procedure, Drugs & Biotech, Injury & Tort Law, Product Liability
In a diet drug product liability litigation, plaintiffs' appeals, challenging the district court's interpretation of a filing fee statute, are...

Warner-Lambert Co. v. Schwarz Pharma, Inc.

Drugs & Biotech, Intellectual Property, Patent
In a patent dispute concerning pharmaceuticals aimed at treating hypertension, the district court erred in granting summary judgment in favor of...

Pfizer, Inc. v. Lott

Civil Procedure, Class Actions, Consumer Protection Law, Drugs & Biotech
The Class Action Fairness Act does not apply to the present class action since the suit was filed in the state court the day before the Act was...

Hoffman-La Roche v. Super. Ct. of Santa Clara

Civil Procedure, Drugs & Biotech, Injury & Tort Law, International Law, Product Liability
In a products liability action concerning a prescription drug, the trial court's exercise of jurisdiction over defendants-Swiss pharmaceutical...

Mass. Eye and Ear Infirmary v. QLT Phototherapeutics, Inc.

Drugs & Biotech, Intellectual Property, Patent
In a dispute over the licensing of Visudyne, a drug that treats vision loss, dismissal of plaintiff's suit is reversed where the allegations...

Showmaker v. Advanta, Inc.

Agriculture, Contracts, Drugs & Biotech
Dismissal of defendant's claim, alleging defendant violated the misbranding provision of the Plant Variety Protection Act (PVPA), is affirmed where...

Merck v. Integra Lifesciences

Drugs & Biotech, Intellectual Property, Patent
The use of patented compounds in preclinical studies is protected under 37 U.S.C. section 271(e)(1) as long as there is a reasonable basis to believe...